Author: Maria Holyanova

Addressing Tetany aka Hand Cramps During a Psychedelic Experience: Causes, Symptoms, Treatment

January 8, 2024June 2, 2024 Beginners, Learn, Treatment

In the event you begin experiencing signs of tetany during a trip and a simple bottle of water isn’t sufficient to reduce symptoms, you should consider:eplenishing your electrolytes right away: The easiest, although not the healthiest solution, will be a bottle or two of Gatorade. However, in the event you have forgotten to bring your electrolytes, you can opt for adding ¼ tbsp salt and 1-2 tbsp of honey in a cup of water, coconut water and lemon juice.

Staying calm: Anxiety will only worsen the symptoms. Consider breathing exercises and changing your setting.

Massaging and stretching your extremities: This will help with blood circulation.

Asking your trip sitter to check your heart rate: Most psychedelic retreats have an ENT on stand-by who can diagnose the need for medical assistance. Oftentimes, it is not necessary if you’re able to replenish your electrolyte levels.

The Biggest Psychedelic News This Week: December 18 – 22

December 22, 2023June 2, 2024 Act, Policy, Research

While yet another study shows psilocybin’s efficacy in treating depression in cancer patients, and 2024 presidential candidates push for a psychedelics reform from all sides, Colorado public health officials fight over manure.

The Biggest Psychedelic News This Week: December 11 – 15

December 15, 2023June 2, 2024 Act, Policy, Research

As MDMA nears FDA approval, LSD’s efficacy in treating generalized anxiety disorder is demonstrated in MindMed’s Phase 2b study. Meanwhile, Congress has approved a psychedelic treatment bill for active duty service members suffering from PTSD.

MDMA-Assisted Therapy for PTSD Edges Toward Acceptance – When Might It Be Approved?

December 13, 2023June 2, 2024 Business, Learn, Research

The FDA will have 60 days “to determine whether the MDMA-AT NDA application will be accepted for review and whether it will be a priority or standard review. The estimate timeline is six months or ten months.

The Biggest Psychedelic News This Week: November 27th – December 1st

December 1, 2023June 2, 2024 Act, Policy, Research

The evidence pile for psilocybin’s efficacy in treating depression is growing with new data demonstrating 79% remission rates after two doses. Meanwhile, early trials hint at MEAI’s efficacy in treating obesity, ketamine studies suggest a single dose is effective in treating anxiety and discussions arise about psychedelic use and its capacity to birth new environmentalists.

The Biggest Psychedelic News This Week: November 20th-24th

November 24, 2023June 2, 2024 Act, Policy, Research

Psilocybin use shows reduced psychological distress in individuals with adverse childhood experiences, while microdosing shows a “both and” approach to treating ADHD.

The Biggest Psychedelic News This Week: November 13th-17th

November 17, 2023June 2, 2024 Act, Policy, Research

Psilocybin can be an useful tool when it comes to reducing nicotine withdrawal, PTSD, and even OCD symptoms. It could also be a hazardous weapon for those who suffer from personality disorders.

The Biggest Psychedelic News This Week: November 6 – 10

November 10, 2023June 2, 2024 Act, Policy, Research

While everyone was preparing to head to Wonderland Miami, the psychedelic space saw a week full of debates! From the FDA’s recommendation to limit psychological support in clinical trials, to debates over the necessity of the ‘trip’ in the psychedelic experience, to whether microdosing’s benefits are influenced by expectancy bias.

The Biggest Psychedelic News This Week: Oct 30th – Nov 3rd

November 3, 2023June 2, 2024 Act, Policy, Research

While unprecedented positive results provide further proof of psilocybin’s anti-depressive effects, other studies investigate the long-term adverse effects of challenging trips. Meanwhile, the DEA wants to increase the manufacturing of certain psychedelics yet again as more psychedelic dispensaries are getting raided in Canada.

End of content